Olsson G, Rehnqvist N
Department of Medicine, Karolinska Institute, Danderyd Hospital, Sweden.
Eur J Clin Pharmacol. 1987;33(3):311-3. doi: 10.1007/BF00637568.
Chronic treatment with metoprolol of postmyocardial infarction patients did not influence the response to an intravenous glucose tolerance test. Treatment with metoprolol of patients with a previously abnormal intravenous glucose tolerance test was not associated with a negative influence on the long-term prognosis.
对心肌梗死后患者长期使用美托洛尔治疗,并不影响其对静脉葡萄糖耐量试验的反应。对既往静脉葡萄糖耐量试验异常的患者使用美托洛尔治疗,与对长期预后产生负面影响无关。